FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:665 February 27, 1997 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Kittner, S. J.

To the Editor: In the report by Kittner et al. (Sept. 12 issue)¹ on pregnancy and the risk of stroke, the relative risk of stroke during the postpartum period was extremely high. During the years of the study, 1988 and 1991, bromocriptine mesylate (Parlodel) was in general use for the postpartum suppression of lactation. The recommendation for the use of bromocriptine for this indication was voluntarily withdrawn in August 1994 because of concern that its use could increase the risk of stroke. I would be very interested to know whether Kittner et al. have any data on the use of . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.